Average Co-Inventor Count = 2.62
ph-index = 27
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Intra-cellular Therapies, Inc. (127 from 167 patents)
2. Takeda Pharmaceutical Company Limited (3 from 1,161 patents)
3. The Rockefeller University (1 from 710 patents)
4. 1ntra-cellular Therap1es, 1nc. (1 from 1 patent)
131 patents:
1. 12414948 - Methods
2. 12410175 - Compounds
3. 12410195 - Pharmaceutical compositions comprising 4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3',4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)phenyl)butan-1-one for treating conditions of the central nervous system and cardiac disorders
4. 12384783 - Salts and crystals
5. 12364695 - Methods of treating inflammatory disease
6. 12364694 - Organic compounds
7. 12358916 - Substituted heterocycle fused gamma-carbolines synthesis
8. 12336989 - Transmucosal methods for treating psychiatric and neurological conditions
9. 12331052 - Organic compounds
10. 12325726 - Organic compounds
11. 12297200 - Substituted heterocycle fused gamma-carbolines synthesis
12. 12280048 - Amorphous solid dispersions
13. 12269825 - Organic compounds
14. 12268686 - Transmucosal methods for treating psychiatric and neurological conditions
15. 12264160 - Pharmaceutical compositions comprising 4-((6bR, 10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H-pyrido[3',4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-1-(4-fluorophenyl)butan-1-one for treating central nervous system disorders